Chiral Epoxy Ether Stereospecific Rearrangement
20
Calcd for C17H18O3 : C, 75.53; H, 6.71. Found: C, 75.75; H, 6.35.
ee ) >99% (HPLC: Chiralcel OD, 5% 2-propanol in hexane, 0.5
mL/min, (S,S) isomer 18.94 min, (R,R) isomer 20.30 min).
(4R)-[(R)-(4-Nitrophenyl)(4-methoxyphenyl)methyl]-1,3-dioxo-
lane (2e). A solution of enantiomerically pure (95% ee) (2S,3S)-
1e (0.050 g, 0.16 mmol) in anhydrous CH2Cl2 (1.6 mL) and
BF3.Et2O (0.03 mL, 0.32 mmol) under N2 was stirred for 30 min
at room temperature. The reaction mixture was treated as described
for 2a, and the crude product was purified by column chromatog-
raphy using hexane:EtOAc (47:3) as the eluent to give 2e (0.014
as an oil: [R]D ) -19.0 (c ) 0.6 in CHCl3); IR (CHCl3) 2940,
2841, 1598, 1326, 1206, 1067, 838 cm-1; H NMR (400 MHz,
1
CDCl3) δ 3.21 (m, 1H), 3.66 (dd, J ) 5.2, 11.6 Hz, 1H), 3.79 (s,
6H), 3.83 (d, J ) 3.2 Hz, 1H), 3.85 (d, J ) 2.8 Hz, 1H), 4.56 (d,
J ) 4.0 Hz, 2H), 6.40 (t, J ) 2.0 Hz, 1H), 6.52 (d, J ) 2.4 Hz,
2H), 7.38 (d, J ) 8.0 Hz, 2H), 7.59 (d, J ) 8.4 Hz, 2H); 13C NMR
(100 MHz, CDCl3) δ 55.2, 55.3, 61.5, 69.5, 73.4, 99.8, 105.5, 125.5
(q, J ) 3.8 Hz), 125.9, 140.1, 141.1, 161.0; 19F NMR (376 MHz,
CDCl3) δ -63.0 (s, CF3); MS (CI, NH3) m/z 386 [M + NH4]+,
369 [M + H]+. HRMS (CI). Calcd for (M)+: 368.1235. Found:
368.1225.
20
g, 28%) as a liquid: [R]D ) + 3.0 (c ) 0.32 in CHCl3); IR
(CHCl3) 2934, 2838, 1607, 1514, 1348, 1251, 1088 cm-1; 1H NMR
(400 MHz, CDCl3) δ 3.60 (dd, J ) 6.4, 8.4 Hz, 1H), 3.78 (s, 3H),
3.89 (dd, J ) 6.4, 8.4 Hz, 1H), 4.06 (d, J ) 9,6 Hz, 1H), 4.72 (m,
1H), 4.94 (s, 1H), 5.08 (s, 1H), 6.85 (d, J ) 8.4 Hz, 2H), 7.13 (d,
J ) 8.4 Hz, 2H), 7.50 (d, J ) 8.4 Hz, 2H), 8.16 (d, J ) 8.4 Hz,
2H); 13C NMR (100 MHz) δ 53.8, 55.3, 69.0, 77.8, 95.7, 114.6,
123.7, 129.2, 129.2, 131.7, 146.6, 149.8, 159.0; MS (CI, NH3)
m/z: 333 [M + NH4]+, 242 (100). HRMS (CI). Calcd for [M +
H]+: 316.1184. Found: 316.1179. ee ) 98.0% (HPLC: Chiralcel
OD, 5% 2-propanol in hexane, 0.5 mL/min, (S,S) isomer 40.91 min,
(R,R) isomer 44.14 min).
(2S,3S)-3-(4-Chlorophenyl)-2-((3,5-dimethoxy)benzyloxy-
methyl)oxirane (4c). A solution of (2S,3S)-2,3-epoxy-3-(chloro-
phenyl)propan-1-ol (0.201 g, 1.09 mmol) in DMF (5 mL) was added
via cannula to a suspension of sodium hydride (0.046 g, 1.15 mmol)
in DMF (5 mL) at -20 °C under N2. The mixture was stirred for
20 min, and 3,5-dimethoxybenzyl bromide (0.28 g, 1.15 mmol) in
DMF (3 mL) was added via cannula to the mixture. After 6 h of
stirring at -20 °C, the reaction mixture was treated as described
for 1a. The residual oil was purified by column chromatography
20
using hexane:ether (48:2) to give 4c (0.25 g, 68%) as an oil: [R]D
) -26.0 (c ) 1.25 in CHCl3); IR (CHCl3) 2939, 2838, 1598, 1458,
1
1205, 1157, 829 cm-1; H NMR (400 MHz, CDCl3) δ 3.19 (m,
(4R)-[(4-Methoxyphenyl)-(R)-(4-chlorophenyl)methyl]-1,3-di-
oxolane (2f). A solution of enantiomerically enriched (80% ee)
(2S,3S)-1f (0.080 g, 0.263 mmol) in anhydrous CH2Cl2 (2.6 mL)
and BF3‚Et2O (0.01 mL, 0.079 mmol) under N2 was stirred for 5
min at -20 °C. The reaction mixture was treated as described for
2a, and the crude product was purified by column chromatography
using hexane:ether (47:3) as the eluent to give 2f (0.035 g, 44%)
1H), 3.62 (dd, J ) 4.8, 11.4 Hz, 1H), 3.76 (d, J ) 1.6 Hz, 1H),
3.79 (s, 6H), 3.82 (dd, J ) 3.2, 11.6 Hz, 1H), 4.55 (d, J ) 4.8 Hz,
2H), 6.39 (t, J ) 2.4 Hz, 1H), 6.52 (d, J ) 2.4 Hz, 2H), 7.19 (d,
J ) 8.4 Hz, 2H), 7.30 (d, J ) 8.4 Hz, 2H); 13C NMR (100 MHz,
CDCl3) δ 55.3, 55.3, 61.2, 69.6, 73.4, 99.8, 105.4, 127.0, 128.7,
134.0, 135.4, 140.1, 160.9; MS (CI, NH3) m/z 352 [M + NH4]+,
335 [M + H]+. HRMS (CI). Calcd for (M + H)+: 335.1050.
Found: 335.1047.
20
as an oil: [R]D ) -2.0 (c ) 0.5 in CHCl3); IR (CHCl3) 2934,
2837, 1512, 1252, 1090, 807 cm-1; 1H NMR (400 MHz, CDCl3) δ
3.56 (dd, J ) 6.4, 8.4 Hz, 1H), 3.77 (s, 3H), 3.87 (dd, J ) 6.4, 8.4
Hz, 1H), 3.94 (d, J ) 9.6 Hz, 1H), 4.66 (m, 1H), 4.93 (s, 1H),
5.05 (s, 1H), 6.83 (d, J ) 8.8 Hz, 2H), 7.12 (d, J ) 8.8 Hz, 2H),
7.27 (s, 4H); 13C NMR (100 MHz) δ 53.2, 55.2, 69.0, 78.1, 95.6,
114.3, 128.6, 129.1, 129.6, 132.4, 132.9, 140.7, 158.6; MS (CI,
NH3) m/z 322 [M + NH4]+, 231 (100%). HRMS (CI). Calcd for
[M]+: 304.0866. Found: 304.0866. ee ) 85% (HPLC: Chiralcel
ODH, 5% 2-propanol in hexane, flux 0.5 mL/min, (S,S) isomer
16.71 min, (R,R) isomer 18.17 min).
(2S,3S)-3-Biphenyl-2-((3,5-dimethoxy)benzyloxymethyl)oxi-
rane (4d). A solution of (2S,3S)-2,3-epoxy-3-(biphenyl)propan-1-
ol (0.238 g, 1.05 mmol) in DMF (5 mL) was added via cannula to
a suspension of sodium hydride (0.044 g, 1.10 mmol) in DMF (5
mL) at -20 °C under N2. The mixture was stirred for 20 min, and
3,5-dimethoxybenzyl bromide (0.27 g, 1.10 mmol) in DMF (3 mL)
was added via cannula to the mixture. After 5 h of stirring at -20
°C, the reaction mixture was treated as described for 1a. The
residual oil was purified by column chromatography using hexane:
ether (48:2) to give 4d (0.24 g, 61%) as an oil: [R]D20 ) -24.5 (c
) 1.0 in CHCl3); IR (CHCl3) 2938, 2838, 1598, 1458, 1205, 1156,
836 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.29 (m, 1H), 3.64 (dd,
J ) 5.2, 11.4 Hz, 1H), 3.79 (s, 6H), 3.83 (d, J ) 2.0 Hz, 1H), 3.86
(dd, J ) 2.8, 11.4 Hz, 1H), 4.57 (d, J ) 4.8 Hz, 2H), 6.40 (t, J )
2.4 Hz, 1H), 6.54 (d, J ) 2.0 Hz, 2H), 7.35 (t, J ) 7.4 Hz, 3H),
7.43 (t, J ) 8.0 Hz, 2H), 7.56 (d, J ) 6.8 Hz, 4H); 13C NMR (100
MHz, CDCl3) δ 55.3, 55.7, 61.2, 69.9, 73.3, 99.8, 105.4, 126.2,
127.0, 127.2, 127.4, 128.8, 135.9, 140.3, 140.6, 141.3, 160.9; MS
(CI, NH3) m/z 394 [M + NH4]+, 377 [M + H]+, 359. HRMS (CI).
Calcd for [M + H]+: 377.1752. Found: 377.1746.
(2S,3S)-3-Phenyl-2-((3,5-dimethoxy)benzyloxymethyl)oxi-
rane (4a). A solution of (2S,3S)-2,3-epoxy-3-phenylpropan-1-ol (1.5
g, 10 mmol) in DMF (5 mL) was added via cannula to a suspension
of sodium hydride (0.42 g, 10.5 mmol) in DMF (20 mL) at -20
°C under N2. The mixture was stirred for 20 min, and 3,5-
dimethoxybenzyl bromide (2.55 g, 10.5 mmol) in DMF (10 mL)
was added via cannula to the mixture. After 3 h of stirring at -20
°C and 4 h of stirring at 0 °C, the reaction mixture was treated as
described for 1a. The residual oil was purified by column
chromatography using hexane:ether (96:4) as eluent to give 4a (1.5
g, 50%): [R]D20 ) -27.0 (c ) 0.98 in CHCl3); IR (CHCl3) 2999,
2939, 2839, 1598, 1462, 835, 698 cm-1 1H NMR (400 MHz,
;
(4R,5S)-1,3,4,5-Tetrahydro-6,8-dimethoxy-5-phenylbenz[c]-
oxepin-4-ol (5a). A solution of enantiomerically pure (ee > 99%)
(2S,3S)-4a (0.104 g, 0.346 mmol) in anhydrous CH2Cl2 (3.5 mL)
and BF3‚Et2O (0.013 mL, 0.104 mmol) under N2 was stirred for
15 min at -78 °C. The reaction mixture was treated as described
for 2a, and the crude product was purified by column chromatog-
raphy using hexane:AcOEt (9:1/8:2) as the eluent to give 5a (0.088
CDCl3) δ 3.25 (m, 1H), 3.61 (dd, J ) 5.2, 11.6 Hz, 1H), 3.78 (s,
6H), 3.85 (dd, J ) 2.8, 11.6 Hz, 1H), 4.56 (d, J ) 5.2 Hz, 1H),
6.39 (t, J ) 2.4 Hz, 1H), 6.53 (d, J ) 2.4 Hz, 2H), 7.25-7.36 (m,
5H); 13C NMR (100 MHz, CDCl3) δ 55.3, 55.9, 61.1, 69.9, 73.3,
99.8, 105.4, 125.7, 128.2, 128.5, 136.8, 140.2, 160.9; MS (CI, NH3)
m/z 318 [M + NH4]+, 301 [M]+. HRMS (CI). Calcd for (M)+:
300.1362. Found: 300.1359.
(2S,3S)-3-(4-(Trifluoromethyl)phenyl)-2-((3,5-dimethoxy)ben-
zyloxymethyl)oxirane (4b). A solution of (2S,3S)-2,3-epoxy-3-(4-
(trifluoromethyl)phenyl)propan1-ol (0.23 g, 1.09 mmol) in DMF
(5 mL) was added via cannula to a suspension of sodium hydride
(0.046 g, 1.15 mmol) in DMF (5 mL) at -20 °C under N2. The
mixture was stirred for 20 min, and 3,5-dimethoxybenzyl bromide
(0.28 g, 1.15 mmol) in DMF (3 mL) was added via cannula to the
mixture. After 6 h of stirring at -20 °C, the reaction mixture was
treated as described for 1a. The residual oil was purified by column
chromatography using hexane:ether (48:2) to give 4b (0.319 g, 79%)
20
g, 80%) as a white solid: mp113-114 °C; [R]D ) -29.6 (c )
1.0 in CHCl3); IR (CHCl3) 3440, 2940, 2839, 1606, 1492, 1153
1
cm-1; H NMR (400 MHz, CDCl3) δ 2.44 (d, J ) 10.4 Hz, 1H),
3.65 (d, J ) 12.8 Hz,), 3.72 (s, 3H), 3.77 (d, J ) 2.4 Hz), 3.84 (s,
3H), 3.95 (dd, J ) 3.2, 12.6 Hz), 4.39 (m, 1H), 4.51 (d, J ) 13.6
Hz, 2H), 5.37 (d, J ) 6.0 Hz, 1H), 6.40 (d, J ) 2.4 Hz, 1H), 6.49
(d, J ) 2.4 Hz, 1H), 7.0 (dd, J ) 1.6, 8.2 Hz, 2H), 7.17 (t, J ) 7.2
Hz, 1H), 7.26 (m, 2H); 13C NMR (100 MHz) δ 46.1, 55.3, 56.0,
71.5, 73.2, 75.9, 98.2, 106.1, 117.4, 126.1, 127.6, 128.5, 139.9,
142.2, 159.5, 160.5; MS (CI, CH4) m/z 318 [M + NH4]+; 301 [M
+ H]+, 283 [M + H - H2O]+. HRMS (CI). Calcd for [M + H]+:
J. Org. Chem, Vol. 71, No. 4, 2006 1543